The global hereditary testing market is expected to grow from USD 5.76 billion in 2019 to USD 9.46 billion by 2027, at a CAGR of 6.4% during the forecast period 2020-2027.
Heredity is the term given to the forwarding of traits to offspring by their parents. There are several diseases which are passed on hereditarily by the parents. Some disorders like migraine, diabetes, cholesterol, heart diseases, etc. occur from the passing of genes. Hereditary testing is done for diagnosis of such diseases. This provides information about the probability of any chronic disease which may be genetically inherited in an individual. Many people, especially women, have adopted hereditary testing for detection of occurrence of the genetic diseases. The rise in demand for screening of newborns and increasing technical advancements for providing accurate analysis are leading the market growth.
This study delivers a comprehensive analysis of disease type, end-users and regions. The disease type segment includes hereditary cancer testing and hereditary non-cancer testing. The cancer testing segment further includes breast cancer testing, lung cancer testing, colorectal cancer testing, ovarian cancer testing, cervical cancer testing, stomach/gastric cancer testing, prostate cancer testing, sarcoma testing, melanoma testing, pancreatic cancer testing, urine cancer testing and others. The non-cancer testing segment includes genetic tests, newborn genetic screening, preimplantation genetic diagnosis & screening and non-invasive prenatal testing (NIPT) & carrier screening tests. Further, the genetic tests sub-segment includes cardiac diseases, rare diseases and other diseases. The cancer test segment holds majority of the market shares. The increasing prevalence of cancer has been a significant factor for the market growth. The number of patients suffering from cancer is increasing worldwide. The probability of recovery is higher in the initial stages. Thus, consumers are becoming more aware of the diagnosis as the disease posses can be passed genetically. Moreover, breast cancer testing dominates the hereditary cancer testing segment. Breast cancer has a high probability of transferability and has high penetration characteristics. The end-user segment includes hospitals, diagnostics, academics & research and laboratories. Hospitals dominate the market share. The increasing infrastructural developments and growing facilities are the major reason for the growth of the segment.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Europe is the dominant market in terms of market share. The availability of a large number of market players offering advance test kits and treatment is the major reason for the penetration of the product in the region.
Some of the notable players of the hereditary testing market are Illumina Inc., Laboratory Corporation of America Holdings, Myriad Genetics Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, CooperSurgical Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., Twist Bioscience, Sophia Genetics, Medgenome, Fulgent Genetics Inc., Invitae Corporation, Natera Inc., CENTOGENE N.V. and others.
This study forecasts revenue growth at global, regional, and country levels from 2020 to 2027. Fior Markets has segmented the market based on below-mentioned segments:
Global Hereditary Testing Market Analysis And Forecast, By Disease Type
Global Hereditary Testing Market Analysis And Forecast, By End-users
Global Hereditary Testing Market Analysis And Forecast, By Region
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Disease Type
4.3.2. Market Attractiveness Analysis By End-users
4.3.3. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restrains
5.4. Opportunities
5.5. Challenges
6. Global Hereditary Testing Market Analysis and Forecast, By Disease Type
6.1. Segment Overview
6.2. Hereditary Cancer Testing
6.2.1. Breast Cancer Testing
6.2.2. Lung Cancer Testing
6.2.3. Colorectal Cancer Testing
6.2.4. Ovarian Cancer Testing
6.2.5. Cervical Cancer Testing
6.2.6. Stomach/Gastric Cancer Testing
6.2.7. Prostate Cancer Testing
6.2.8. Sarcoma Testing
6.2.9. Melanoma Testing
6.2.10. Pancreatic Cancer Testing
6.2.11. Urine Cancer Testing
6.2.12. Others
6.3. Hereditary Non-cancer Testing
6.3.1. Genetic Tests
6.3.2. Cardiac Diseases
6.3.3. Rare Diseases
6.3.4. Other Diseases
6.3.5. Newborn Genetic Screening
6.3.6. Preimplantation Genetic Diagnosis and Screening
6.3.7. Non-Invasive Prenatal Testing (NIPT) and Carrier Screening Tests
7. Global Hereditary Testing Market Analysis and Forecast, By End-users
7.1. Segment Overview
7.2. Hospitals
7.3. Diagnostics
7.4. Academics and Research
7.5. Laboratories
8. Global Hereditary Testing Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Hereditary Testing Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in Global Hereditary Testing Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Illumina Inc.
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Laboratory Corporation of America Holdings
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Myriad Genetics Inc.
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. F. Hoffmann-La Roche Ltd.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Quest Diagnostics Incorporated
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. CooperSurgical Inc.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. Agilent Technologies Inc.
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Thermo Fisher Scientific Inc.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Twist Bioscience
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Sophia Genetics
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
2. Global Hereditary Cancer Testing, Hereditary Testing Market, By Region, 2017–2027(USD Billion)
3. Global Hereditary Non-cancer Testing, Hereditary Testing Market, By Region, 2017–2027(USD Billion)
4. Global Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
5. Global Hospitals Hereditary Testing Market, By Region, 2017–2027(USD Billion)
6. Global Diagnostics Hereditary Testing Market, By Region, 2017–2027(USD Billion)
7. Global Academics and Research Hereditary Testing Market, By Region, 2017–2027(USD Billion)
8. Global Laboratories Hereditary Testing Market, By Region, 2017–2027(USD Billion)
9. Global Hereditary Testing Market, By Region, 2017–2027(USD Billion)
10. Global Hereditary Testing Market, By North America, 2017–2027(USD Billion)
11. North America Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
12. North America Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
13. U.S. Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
14. U.S. Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
15. Canada Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
16. Canada Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
17. Mexico Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
18. Mexico Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
19. Europe Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
20. Europe Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
21. Germany Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
22. Germany Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
23. France Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
24. France Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
25. U.K. Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
26. U.K. Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
27. Italy Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
28. Italy Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
29. Spain Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
30. Spain Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
31. Asia Pacific Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
32. Asia Pacific Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
33. Japan Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
34. Japan Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
35. China Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
36. China Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
37. India Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
38. India Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
39. South America Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
40. South America Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
41. Brazil Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
42. Brazil Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
43. Middle East and Africa Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
44. Middle East and Africa Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
45. UAE Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
46. UAE Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
47. South Africa Hereditary Testing Market, By Disease Type , 2017–2027(USD Billion)
48. South Africa Hereditary Testing Market, By End-users, 2017–2027(USD Billion)
List of Figures
1. Global Hereditary Testing Market Segmentation
2. Hereditary Testing Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Hereditary Testing Market Attractiveness Analysis By Disease Type
9. Global Hereditary Testing Market Attractiveness Analysis By End-users
10. Global Hereditary Testing Market Attractiveness Analysis By Region
11. Global Hereditary Testing Market: Dynamics
12. Global Hereditary Testing Market Share By Disease Type (2019 & 2027)
13. Global Hereditary Testing Market Share By End-users (2019 & 2027)
14. Global Hereditary Testing Market Share by Regions (2019 & 2027)
15. Global Hereditary Testing Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.